Literature DB >> 20606586

Sepsis in burns: a review of current practice and future therapies.

Elizabeth Chipp1, Christopher S Milner, Adam V Blackburn.   

Abstract

Sepsis is a major cause of death worldwide and remains the subject of much research and debate within the critical care community. Despite advances in burn prevention, treatment, and rehabilitation, sepsis remains a common cause of death in patients who have sustained a severe burn injury. The unique physical, metabolic, and physiologic changes seen after major thermal injury mean that the management of sepsis in burns poses a particular challenge and differs in many respects to the management of sepsis in the general critical care population. This article describes current issues in the prevention, diagnosis, and treatment of sepsis in burns with a review of the associated literature. In addition, we discuss possible future therapies for managing this condition.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20606586     DOI: 10.1097/SAP.0b013e3181c9c35c

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  17 in total

Review 1.  [Antimicrobial treatment in burn injury patients].

Authors:  T Trupkovic; J Gille; H Fischer; S Kleinschmidt
Journal:  Anaesthesist       Date:  2012-03       Impact factor: 1.041

2.  The extracellular matrix protein matrilin-2 induces post-burn inflammatory responses as an endogenous danger signal.

Authors:  Yunfei Chi; Jiake Chai; Chengfeng Xu; Hongmin Luo; Qinxue Zhang
Journal:  Inflamm Res       Date:  2015-08-14       Impact factor: 4.575

3.  Resolvin D2 restores neutrophil directionality and improves survival after burns.

Authors:  Tomohiro Kurihara; Caroline N Jones; Yong-Ming Yu; Alan J Fischman; Susumu Watada; Ronald G Tompkins; Shawn P Fagan; Daniel Irimia
Journal:  FASEB J       Date:  2013-02-21       Impact factor: 5.191

4.  Baseline assessment of inpatient burn care at Tenwek Hospital, Bomet, Kenya.

Authors:  Craig R Otteni; Seno Ivan Saruni; Vincent P Duron; Jeremy P Hedges; Russell E White
Journal:  World J Surg       Date:  2013-07       Impact factor: 3.352

5.  The clinical significance of the MIF homolog d-dopachrome tautomerase (MIF-2) and its circulating receptor (sCD74) in burn.

Authors:  Bong-Sung Kim; Christian Stoppe; Gerrit Grieb; Lin Leng; Maor Sauler; David Assis; David Simons; Arne Hendrick Boecker; Wibke Schulte; Marta Piecychna; Stephan Hager; Jürgen Bernhagen; Norbert Pallua; Richard Bucala
Journal:  Burns       Date:  2016-05-18       Impact factor: 2.744

6.  Treatment with gelsolin reduces brain inflammation and apoptotic signaling in mice following thermal injury.

Authors:  Qing-Hong Zhang; Qi Chen; Jia-Rui Kang; Chen Liu; Ning Dong; Xiao-Mei Zhu; Zhi-Yong Sheng; Yong-Ming Yao
Journal:  J Neuroinflammation       Date:  2011-09-21       Impact factor: 8.322

Review 7.  Burn wound healing and treatment: review and advancements.

Authors:  Matthew P Rowan; Leopoldo C Cancio; Eric A Elster; David M Burmeister; Lloyd F Rose; Shanmugasundaram Natesan; Rodney K Chan; Robert J Christy; Kevin K Chung
Journal:  Crit Care       Date:  2015-06-12       Impact factor: 9.097

8.  Circulating Syndecan-1 and Tissue Factor Pathway Inhibitor, Biomarkers of Endothelial Dysfunction, Predict Mortality in Burn Patients.

Authors:  John W Keyloun; Tuan D Le; Anthony E Pusateri; Robert L Ball; Bonnie C Carney; Thomas Orfeo; Kathleen E Brummel-Ziedins; Maria C Bravo; Melissa M McLawhorn; Lauren T Moffatt; Jeffrey W Shupp
Journal:  Shock       Date:  2021-08-01       Impact factor: 3.533

9.  High-mobility group box-1 induces proinflammatory cytokines production of Kupffer cells through TLRs-dependent signaling pathway after burn injury.

Authors:  Xu-Lin Chen; Li Sun; Feng Guo; Fei Wang; Sheng Liu; Xun Liang; Ren-Su Wang; Yong-Jie Wang; Ye-Xiang Sun
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

10.  Surviving an Extensive Burn Injury Using Advanced Skin Replacement Technologies.

Authors:  Charis Kelly; David Wallace; Veronique Moulin; Lucie Germain; Jennifer Zuccaro; Izabela Galdyn; Joel S Fish
Journal:  J Burn Care Res       Date:  2021-11-24       Impact factor: 1.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.